Expression of cytokeratin 7 and 20 in ovarian metastatic carcinomas

Lin DAI,Qiujing SONG,Lihua LI,Dajun Zhong,Yunzhong HUI
DOI: https://doi.org/10.3760/j.issn:0529-5807.2001.02.008
2001-01-01
Abstract:Objective  To study the distinctive clinicopathologic and immunohis tochemical difference between ovarian metastatic carcinomas and primary ovarian carcinom as. Methods  The clinical and pathological features of 27 cases of ovaria n metastatic carcinomas (gastric carcinomas 12 cases, colon carcinomas 11 cases, others 4 cases) obtained from our department were reviewed. Immunostaini ngs for CK(AE1/AE3), CK7, CK20,CEA, vimentin, nm23 were performed with SP staini ng methods. Results  On gross examination, metastasis from gastric adenocarcinoma were usually bilateral, while solid (11/12) and metastases from colonic adenoca rcinoma were more often unilateral and cystic (7/11). Microscopically, metastases fr om gastric adenocarcinoma revealed signet ring cells or poorly differentiated adenocarcinom as (12/12), whereas metastases from colonic adenocarcinomas showed similar morph ology of endometrioid adenocarcinoma (8/11). The majority of ovarian metastases of gastr ic car cinoma (7/12) and colon carcinoma (8/11) were CK20 positive. In particular, CK20 was invariably expressed in colon cancer metastases. Most of the ovarian metastatic carcinomas from the gastrointestinal tract failed to react with immunostaining of CK7. A combined use of CEA, vimentin and nm23 had made a correct classification for 11/ 12 cases of the gastric carcinoma, 10/11 cases of the colonic cancer. Conclusions  CK7 and CK20 have been proved to be useful antibodies in distinguishing b etween metastatic carcinomas and primary carcinomas of the ovary. Combined use of a panel of antibodies can give more significant results.
What problem does this paper attempt to address?